Literature DB >> 6595251

A unifying concept for carcinogenic risk assessments: comparison with radiation-induced leukemia in mice and men.

T D Jones.   

Abstract

This paper presents a new, general mathematical dose-response model which can use human, animal and cell culture data to predict the incidence of leukemia as a result of exposure to ionizing radiations. The model is based on simple considerations of fundamental biological processes of carcinogenic initiation, carcinogenic promotion and competing risk due to other toxic or disease reactions. The model can be used to predict the risk of leukemia for either human or animal populations which have been (or will be) treated with any radiation dose-time treatment protocol of interest. The model is both an extension and an outgrowth of earlier work done for the Oak Ridge dosimetry program in support activities for the Atomic Bomb Casualty Commission (formerly) and the Radiation Effects Research Foundation (currently).

Entities:  

Mesh:

Year:  1984        PMID: 6595251     DOI: 10.1097/00004032-198410000-00002

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  4 in total

Review 1.  Dietary carcinogens, environmental pollution, and cancer: some misconceptions.

Authors:  B N Ames; L S Gold
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

2.  Chemical carcinogenesis: too many rodent carcinogens.

Authors:  B N Ames; L S Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  A RASH analysis of National Toxicology Program data: predictions for 30 compounds to be tested in rodent carcinogenesis experiments.

Authors:  T D Jones; C E Easterly
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

Review 4.  DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis.

Authors:  B N Ames; M K Shigenaga; L S Gold
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.